Anthony J. Turner

Active 1972–2024

109
Papers
22,510
Citations
91
h-index
108
i10-index

Citations

Citations per year for Anthony J. Turner1973: 1 citations1976: 1 citations1977: 2 citations1978: 2 citations1979: 5 citations1980: 5 citations1981: 1 citations1982: 4 citations1983: 6 citations1984: 13 citations1985: 26 citations1986: 21 citations1987: 37 citations1988: 39 citations1989: 40 citations1990: 36 citations1991: 47 citations1992: 34 citations1993: 38 citations1994: 30 citations1995: 71 citations1996: 65 citations1997: 84 citations1998: 87 citations1999: 117 citations2000: 115 citations2001: 114 citations2002: 117 citations2003: 174 citations2004: 183 citations2005: 199 citations2006: 211 citations2007: 202 citations2008: 214 citations2009: 198 citations2010: 208 citations2011: 194 citations2012: 211 citations2013: 170 citations2014: 180 citations2015: 142 citations2016: 125 citations2017: 111 citations2018: 94 citations2019: 317 citations2020: 1,542 citations2021: 1,182 citations2022: 527 citations2023: 280 citations2024: 350 citations2025: 103 citations2026: 3 citations1974–1975: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,225 citing papers, 24.8% of this breakdownChina: 699 citing papers, 7.8% of this breakdownUnited Kingdom: 650 citing papers, 7.3% of this breakdownGermany: 504 citing papers, 5.6% of this breakdownItaly: 402 citing papers, 4.5% of this breakdownCanada: 344 citing papers, 3.8% of this breakdownFrance: 321 citing papers, 3.6% of this breakdownIndia: 310 citing papers, 3.5% of this breakdownJapan: 271 citing papers, 3% of this breakdownAustralia: 249 citing papers, 2.8% of this breakdownBrazil: 226 citing papers, 2.5% of this breakdownSpain: 222 citing papers, 2.5% of this breakdown
0%24.8%Other 28.3%

Fields

  • Medicine66.3%
  • Biochemistry, Genetics and Molecular Biology19.9%
  • Neuroscience6.4%
  • Computer Science1.8%
  • Immunology and Microbiology1.6%
  • Nursing0.8%
  • Other3.2%

Topics

  • COVID-19 Clinical Research Studies7.6%
  • Alzheimer's disease research and treatments5.5%
  • SARS-CoV-2 and COVID-19 Research5.4%
  • Renin-Angiotensin System Studies4.3%
  • Long-Term Effects of COVID-193.3%
  • Computational Drug Discovery Methods2.5%
  • Other71.4%

Coauthors

All papers

Open in search
  1. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System

    Authors: , , , , , , , , - Circulation Research 2020 cited by 1,907

  2. A Human Homolog of Angiotensin-converting Enzyme

    Authors: , , , , , - Journal of Biological Chemistry 2000 cited by 2,029

  3. Neprilysin expression and functions in development, ageing and disease

    Authors: , , - Mechanisms of Ageing and Development 2020 cited by 164

  4. Tumor Necrosis Factor-α Convertase (ADAM17) Mediates Regulated Ectodomain Shedding of the Severe-acute Respiratory Syndrome-Coronavirus (SARS-CoV) Receptor, Angiotensin-converting Enzyme-2 (ACE2)

    Authors: , , , , , , , - Journal of Biological Chemistry 2005 cited by 712

  5. Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy

    Authors: , - British Journal of Pharmacology 2019 cited by 179

  6. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism

    Authors: , , , , - Biochemical Journal 2004 cited by 627

  7. Exclusively targeting β-secretase to lipid rafts by GPI-anchor addition up-regulates β-site processing of the amyloid precursor protein

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 360

  8. The amyloid precursor protein: A biochemical enigma in brain development, function and disease

    Authors: , - FEBS Letters 2013 cited by 262

  9. Lipid Rafts and Alzheimer’s Disease: Protein-Lipid Interactions and Perturbation of Signaling

    Authors: , , - Frontiers in Physiology 2012 cited by 206

  10. Neprilysin, obesity and the metabolic syndrome

    Authors: , , , , , , , , , , - International Journal of Obesity 2010 cited by 171

  11. ACE2: from vasopeptidase to SARS virus receptor

    Authors: , , - Trends in Pharmacological Sciences 2004 cited by 536

  12. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS

    Authors: , , , , , , , , , - Journal of Molecular and Cellular Cardiology 2013 cited by 333

  13. The Transcriptionally Active Amyloid Precursor Protein (APP) Intracellular Domain Is Preferentially Produced from the 695 Isoform of APP in a β-Secretase-dependent Pathway

    Authors: , , , , , , , - Journal of Biological Chemistry 2010 cited by 208

  14. Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration

    Authors: , , - Frontiers in Neuroscience 2018 cited by 178

  15. ACE2 Cell Biology, Regulation, and Physiological Functions

    Authors: - Elsevier eBooks 2015 cited by 129

  16. Shedding light on ADAM metalloproteinases

    Authors: , , , , - Trends in Biochemical Sciences 2005 cited by 450

  17. The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function

    Authors: , , - BioEssays 2001 cited by 449

  18. Angiotensin-converting Enzyme 2 (ACE2), But Not ACE, Is Preferentially Localized to the Apical Surface of Polarized Kidney Cells

    Authors: , , , , , - Journal of Biological Chemistry 2005 cited by 192

  19. Amyloid-Degrading Enzymes as Therapeutic Targets in Alzheimers Disease

    Authors: , , , - Current Alzheimer Research 2008 cited by 178

  20. Processing and metabolism of peptide-YY: pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11.

    Authors: , - Endocrinology 1994 cited by 149

  21. ADAMs family members as amyloid precursor protein α‐secretases

    Authors: , , , - Journal of Neuroscience Research 2003 cited by 430

  22. Angiotensin-Converting Enzyme 2: The First Decade

    Authors: , - International Journal of Hypertension 2011 cited by 234

  23. Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress

    Authors: , , , - Clinical Science 2013 cited by 186

  24. The angiotensin–converting enzyme gene family: genomics and pharmacology

    Authors: , - Trends in Pharmacological Sciences 2002 cited by 403